SKLZ Surges 65.8% as EPS Estimates Jump 1.0pp — Top Movers Today
SKLZ led today's EPS revision-driven rally with a 65.8% surge to $4.08 after next-year estimates rose from 34.9% to 35.8%. AEHR followed with a 39.2% gain to $87.91 as analysts massively revised EPS growth from 198% to 266.7%, adding 68.6pp in a single revision. XELB and AGL rounded out strong performers with gains exceeding 38%, as growth-oriented names across tech, healthcare, and cyclical sectors attracted renewed interest.
| Ticker | Sector | Detected | EPS Revision | Gain Since Detection |
|---|---|---|---|---|
| SKLZ | Communication Services | 2026-04-12 | +1.0pp | +65.8% |
| XELB | Consumer Cyclical | 2026-04-10 | N/A | +48.1% |
| AEHR | Technology | 2026-04-08 | +68.6pp | +39.2% |
| AGL | Healthcare | 2026-04-09 | N/A | +38.2% |
| BE | Industrials | 2026-04-09 | +1.5pp | +31.6% |
SKLZ — Skillz Inc
SKLZ surged 65.8% from $2.46 to $4.08 in four trading sessions after the EPS screener detected next-year estimates climbing from 34.9% to 35.8%. The communication services sector saw renewed appetite for gaming-adjacent names as growth sentiment returned to markets mid-April. Without recent news catalysts, the move reflects market-wide recognition that prior estimates were too conservative for Skillz's mobile gaming platform model. The magnitude of price appreciation—double the EPS revision percentage—suggests short covering layered atop fundamental re-rating, as the stock had traded near lows before the estimate revision flashed an early signal. Traders who monitored screener alerts captured this move before the broader market processed the earnings trajectory improvement.
View screener snapshot from 2026-04-12 →XELB — Xcel Brands Inc
Xel Brands rallied 48.1% from $1.33 to $1.97 since April 10th on 64.2% implied next-year EPS growth. The consumer cyclical sector benefited from improving consumer spending outlook as economic data stabilized in early April. XELB's small-cap status made it susceptible to outsized moves when positive earnings signals emerged, as institutional investors sorted through micro-cap opportunities for hidden growth. The stock had traded with thin volume prior to the EPS estimate becoming visible on screeners, and the subsequent price discovery reflected how efficiently the market absorbed better forward earnings expectations. Retail investors following screener alerts could have entered near $1.35-$1.40, catching the bulk of the subsequent 48% appreciation.
View screener snapshot from 2026-04-10 →AEHR — Aehr Test Systems
Aehr Test Systems delivered the most dramatic EPS revision on today's list, with next-year growth estimates soaring from 198% to 266.7%—a 68.6 percentage point jump that propelled the stock 39.2% higher from $63.16 to $87.91. The technology sector's semiconductor testing subsegment has seen mounting demand projections as chip manufacturers accelerate capital expenditure plans for advanced packaging and burn-in testing equipment. When analysts raised AEHR's estimates by that magnitude, the market responded with a proportional price adjustment over eight trading days. The implied forward P/E compression despite the higher price suggests earnings power is being revalued beyond the headline percentage increase, indicating Aehr's backlog and customer commitments likely warrant the revised estimates.
View screener snapshot from 2026-04-08 →AGL — Agilon Health Inc
Agilon Health climbed 38.2% to $27.41 from a $19.84 entry point on April 9th, with next-year EPS growth estimates standing at 25.1%. The healthcare services subsector benefited from policy clarity improving investor sentiment toward value-based care models. AGL's position as a platform enabling physician groups to transition from fee-for-service to capitated arrangements gained credibility as reimbursement headwinds eased. The 38% price gain significantly outpaced the 25% earnings growth projection, suggesting the market assigned a multiple expansion premium to Agilon's scaled network and proven operating model. Early screener detection meant investors captured this move before the healthcare sector rotation fully materialized.
View screener snapshot from 2026-04-09 →BE — Bloom Energy Corp
Bloom Energy advanced 31.6% from $160.13 to $210.80 after next-year EPS estimates ticked up from 106.9% to 108.4%, adding 1.5 percentage points. The industrials sector broadly outperformed as infrastructure spending expectations and clean energy transition timelines gained traction. Bloom's solid oxide electrolyzer and fuel cell technology positions it as a direct beneficiary of hydrogen economy buildout and data center power demand. Even a modest EPS revision triggered significant price appreciation because the stock had traded with compressed multiples amid broader market uncertainty. The combination of 108% implied earnings growth and the 31% price gain indicates investors are willing to assign premium valuations to companies demonstrating accelerating clean energy project pipelines.
View screener snapshot from 2026-04-09 →Today's strongest movers cluster around growth re-rating across technology, clean energy, and small-cap cyclical names, suggesting investors are selectively buying earnings momentum after the April correction cleared weak hands.
How We Identify These Stocks
We track daily changes in forward EPS estimates across thousands of US equities. When a stock's next-year earnings growth estimate is revised upward — confirmed by improvement in current-year estimates — it enters our watchlist. The stocks above were flagged on their detection dates and have since delivered the strongest price returns among all detected stocks.
Explore today's full screener →